FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
Back to search
Official data from USPTO
AMPHIPROTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/06/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/30/2022
Registration date
03/05/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/05/2024
Last transaction
03/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CN
Examiner
CLYBURN, DIONNE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Shanghai Puyou Biomedical Co., Ltd.
Representatives
David M. Perry Blank Rome LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposespharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of liver diseases; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; Medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the treatment of infectious diseasesblood disordersimmune system related diseasestumoursthyroid diseasecardiovascular and cerebrovascular diseasesinflammation and cancer; Biological preparations for medical purposes for the treatment of cancerinsomnia and heart disease; Biological preparations for medical purposes for the prevention and treatment of liver diseases; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; Biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; Drugsinsulin for the treatment of diabetes for medical purposes; Pharmaceutical preparationsanalgesicsantibiotics and aspirin; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; Pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; Medicines in form of tablet form for the treatment of cancerinsomnia and heart disease; Medicines in form of tablet form for the prevention and treatment of liver diseases; Medicines in form of tablet form for the prevention and treatment of respiratory system disorders; Medicines in form of tablet form for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; Medicines in form of tablet form for the prevention and treatment of gastro-intestinal diseases; Medicines in form of tablet form for the prevention and treatment of immune system related diseases and disorders; Medicines in form of tablet form for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; Biochemical medicines for the treatment of cancerinsomnia and heart disease; Biochemical medicines for the prevention and treatment of liver diseases; Biochemical medicines for the prevention and treatment of respiratory system disorders; Biochemical medicines for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; Biochemical medicines for the prevention and treatment of gastro-intestinal diseases; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders; Biochemical medicines for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; Capsules for medicines for the treatment of cancerinsomnia and heart disease; Capsules for medicines for the prevention and treatment of liver diseases; Capsules for medicines for the prevention and treatment of respiratory system disorders; Capsules for medicines for the prevention and treatment of ocular disorders or diseasesbacteria-based diseasesdiabetes; Capsules for medicines for the prevention and treatment of gastro-intestinal diseases; Capsules for medicines for the prevention and treatment of immune system related diseases and disorders; Capsules for medicines for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; Injectable medicinal solutionsdermal fillers; Injectable medicinal solutionsinjectable contraceptives; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purposes
Publications
History of USPTO decisions and trademark events.
22 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2023
PUBO
PUBLISHED FOR OPPOSITION
12/19/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2023
RFNT
REFUSAL PROCESSED BY IB
10/17/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/28/2023
RFRR
REFUSAL PROCESSED BY MPU
09/28/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/16/2023
CNRT
NON-FINAL ACTION WRITTEN
09/15/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/20/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/19/2023
Continuous trademark protection
Get notified about every new filing that threatens AMPHIPROTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.